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Abstract
Cardiovascular complications are common in patients with Diabetes mellitus
(DM). In addition to changes in cardiac muscle inotropy, electrical abnormalities are also commonly observed in these patients. We have previously shown
that spontaneous cellular electrical activity is altered in atrioventricular nodal
(AVN) myocytes, isolated from the streptozotocin (STZ) rat model of type-1
DM. In this study, utilizing the same model, we have characterized the
changes in L-type calcium channel activity in single AVN myocytes. Ionic currents were recorded from AVN myocytes isolated from the hearts of control
rats and from those with STZ-induced diabetes. Patch-clamp recordings were
used to assess the changes in cellular electrical activity in individual myocytes.
Type-1 DM significantly altered the cellular characteristics of L-type calcium
current. A reduction in peak ICaL density was observed, with no corresponding
changes in the activation parameters of the current. L-type calcium channel
current also exhibited faster time-dependent inactivation in AVN myocytes
from diabetic rats. A negative shift in the voltage dependence of inactivation
was also evident, and a slowing of restitution parameters. These findings
demonstrate that experimentally induced type-1 DM significantly alters AVN
L-type calcium channel cellular electrophysiology. These changes in ion channel activity may contribute to the abnormalities in cardiac electrical function
that are associated with high mortality levels in patients with DM.

Introduction
Cardiovascular complications are common and well documented in patients with type 1 and type 2 DM, leading to
an increased risk of mortality (Laing et al. 2003). Disorders of the vasculature, particularly coronary artery disease and hypertension present a two to eightfold
increased incidence of mortality in individuals with DM
(Malmberg et al. 2001). However, diabetic patients are
also at a greater risk of developing cardiac abnormalities,
independently of vascular dysfunction, indicative of a
distinct diabetic cardiomyopathy (Piccini et al. 2004;

Poornima et al. 2006). Evidence from work on experimental models of DM has shown significant impairment
of ventricular mechanical function, particularly a reduction in the speed and duration of contraction, and a delay
in lusitropy (Bouchard and Bose 1991; Choi et al. 2002).
The changes are generally attributed to an alteration in
myocyte intracellular calcium handling, and prior studies
have observed parallel reductions in the rate of rise and
decline of intracellular Ca2+ transient activity elicited by
electrical stimulation (Choi et al. 2002; Pereira et al.
2006). These events have been attributed to a variety of
factors, including altered ryanodine receptor 2 expression
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and function, sarcoplasmic reticulum (SR) pump activity,
SR calcium storage, and altered Na+/Ca2+ exchange activity (Ganguly et al. 1983; Bouchard and Bose 1991; Schaffer et al. 1997; Yaras et al. 2005).
In addition to altering cardiac contractile properties,
DM has a profound effect on the electrical function of
the myocardium. Patients have a significantly greater risk
of electrical dysfunction, which can manifest as a diverse
variety of arrhythmias. QT interval and QRS prolongation
are commonly seen and correlate with an increased incidence of sudden cardiac death in diabetic patients (Casis
and Echevarria 2004; Movahed 2007; Nakou et al. 2012).
Studies have also observed a significant prevalence of
atrial fibrillation, in diabetic patients compared to nondiabetic patients (Nichols et al. 2009). Moreover, there is
evidence to suggest that AV blocks show greater incidence
in diabetic patients compared to the general population
(Fairfax and Leatham 1975; Okamoto et al. 1997; Movahed et al. 2005).
Arrhythmogenic activity can result from abnormalities
in the conduction properties of the cardiac impulse (Kleber
and Rudy 2004), and previous studies using the STZ model
of DM have shown that conduction is attenuated in the rat
myocardium (Nygren et al. 2007). The changes in conduction may reflect alterations in intercellular gap junctional
coupling, manifested by altered expression and activity of
connexin proteins 43 and 40 (Howarth et al. 2007a).
Moreover, a common substrate for the generation of many
arrhythmias, is an imbalance of ionic current fluxes that
underlie the cardiac action potential (Marban 2002).
Changes in cardiac ion channel activity occur in animal
models of DM, which result in an increased action potential duration (Nobe et al. 1990; Yuill et al. 2010). Previous studies have shown that DM may modify ventricular
potassium currents, the transient outward potassium current (Jourdon and Feuvray 1993; Shimoni et al. 1994),
the rapid delayed potassium current (Zhang et al. 2006),
and the slow delayed rectifier potassium current (Lengyel
et al. 2008), thus influencing the repolarization reserve.
However, perhaps of greater importance, is the evidence
that DM has been shown to modify calcium entry
through L-type voltage-dependent calcium channels, the
molecular mediators that permit calcium influx required
for excitation–contraction coupling. Studies in rabbits,
and rats with alloxan, and STZ-induced DM have shown
that L-type calcium channel activity is depressed (Wang
et al. 1995; Chattou et al. 1999) in ventricular myocytes,
and similar findings were observed in a mouse genetic
model of type 1 DM (Lu et al. 2007). Furthermore, there
is very little information available of the effects of DM on
cardiac ion channel function in different cardiac regions,
as much of the work to date, has been conducted in ventricular tissue. Studies by Howarth and colleagues
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(Howarth et al. 2007b) demonstrated that DM can induce
changes in sinoatrial node (SAN) conduction and function, during rapid induction of the diabetic state. We
have also previously demonstrated that a short-term STZ
model of DM can increase action potential duration and
modify whole cell membrane conductances recorded unselectively, in rat AVN mycoytes (Yuill et al. 2010). Studies
as far back as the 1970s demonstrated the importance of
L-type Ca2+ channels, which at the time were called slow
channels, to AV node conduction (Zipes and Mendez
1973; Zipes and Fischer 1974). L-type calcium channels
are fundamental to normal activity in the AVN region
(Hancox et al. 1993). They are responsible for mediating
the action potential upstroke, and are therefore responsible for the timing of conduction velocity through the
AVN, contributing to PR interval duration (Zipes and
Mendez 1973; Zipes and Fischer 1974). Modification of
L-type Ca2+ channel properties either by altered trafficking and expression, or posttranslational modification of
channel gating properties, can therefore have a significant
impact on AVN function, and result in clinical AV abnormalities. The aim of this study was to characterize the
electrophysiological changes induced by DM, using the
well-established STZ model on the L-type calcium current
(ICaL) recorded from AVN myocytes.

Materials and Methods
Ethical approval
All experiments were performed in accordance with local
Ethical Committee approval, United Arab Emirates
University, Al Ain.

Induction of DM
Male Wistar rats received a single intraperitoneal injection
of STZ (Sigma, St. Louis, MO) at 60 mg/kg to induce
diabetes. STZ was prepared in citrate buffer (sodium
citrate/citric acid, 10 mmol/L, pH 4.5) immediately before
administration. The induction of a diabetic state was confirmed prior to experimentation by an elevated blood glucose concentration of 440.9  12.3 mg/dL compared to
control levels of 97.7  6.2 mg/dL, measured using a glucometer. All animals were maintained for a minimum of
12 weeks on the same diet and water. Age-matched male
rats (302.6  9.6 g) were used as control animals. STZ
rats had a significantly smaller body mass, 239.2  6.3 g.

Atrioventricular myocyte isolation
Control (n = 14) and STZ-treated diabetic rats (n = 14)
were killed by cervical dislocation and decapitated. The
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heart was rapidly removed from the chest cavity, and
placed in ice-cold isolation solution prior to aortic cannulation, and subsequent retrograde Langendorff perfusion (6 mL/min/g heart tissue). The hearts from control
animals had a mean weight of 1.17  0.04 g and those
from STZ animals weighed 0.96  0.02 g. In the first
instance, the hearts were perfused for 2 min with isolation solution containing the following constituents (in
mmol/L): NaCl (130), Hepes (10), glucose (5), taurine
(20), creatine (5), KCl (4.5), NaH2PO4 (1), Na-pyruvate
(5), MgCl2 (5), and CaCl2 (0.75 lmol/L) (pH adjusted
to 7.25 with NaOH, and bubbled with 100% O2). The
hearts were then perfused with calcium-’free’ isolation
solution, containing 8 lmol/L Na-EGTA, before switching to isolation solution containing CaCl2 (150 lmol/L),
collagenase type 2 (1 mg/mL, Worthington), protease
type X1V (0.1 mg/mL, Sigma), and bovine serum albumin (1%, Sigma) for 6–10 min. Hearts were then
removed from the cannula, the AVN region was identified and excised, and AVN myocytes were isolated by
enzymatic and mechanical dispersion (Hancox et al.
1993; Yuill et al. 2010). After isolation, cells were stored
in a high [K+], low [Ca2+] storage solution at 4°C for
use on the same day. This contained (mmol/L) L-glutamate (110), KCl (30), Na-pyruvate (5); Taurine (20),
creatine (5), succinic acid (5), Na2ATP (2), b-hydroxybutyrate (5), glucose (9); MgCl2 (5), EGTA (0.05),
HEPES (10), phosphocreatine (1), K2HPO4, (5), and had
a pH of 7.2.

Electrophysiological recordings
Isolated AVN myocytes were placed in a recording chamber, mounted on an inverted microscope. They were
allowed to adhere to the glass base of the chamber, before
commencing continuous perfusion with normal Tyrodes
solution at 37°C containing (in mmol/L) NaCl (140), KCl
(5), 1.2 MgCl2, glucose (5), HEPES (5), and CaCl2 (2)
(pH adjusted to 7.4 with NaOH). To ensure that only
nodal cells were included in the study, only those cells
exhibiting spontaneous rhythmic beating were selected for
recording. Experiments were performed using a Cs+-based
pipette solution containing (in mmol/L): CsCl (130),
NaCl (10), MgATP (1), Hepes 10, BAPTA (5), and
amphotericin B (200 lg/mL) (pH adjusted to 7.2 with
KOH). The amphotericin-perforated patch technique was
used to minimize dialysis of cytoplasmic constituents and
generally reduce rundown (Yuill et al. 2010). Patch pipettes (Corning 7052 glass, AM Systems, Everett, MD)
were pulled using a Model P2000 puller (Sutter Instruments, Novato, CA) and fire polished on a microforge
(MF-83 Narishige) to resistances of ~5 MΩ. Recordings
were made using an Axopatch 200B amplifier. Data were

Diabetes and the Atrioventricular Node

digitized using a Digidata 1322A A/D interface and
acquired using Clampex software (Molecular Devices, Sunnyvale, CA). Capacitative transient currents elicited by a
10 mV hyperpolarizing step were measured and compensated. The area under the transient was used to calculate cell
membrane capacitance, enabling comparison of cell surface
area of AVN myocytes from both control and STZ-treated
animals.

Drugs and chemicals
Aristar grade chemicals (BDH) dissolved in deionized
water (18.4 MΩ) were used for myocyte isolation and
pipette solutions, while Analar grade chemicals (BDH)
were utilized for external solutions. All drugs were supplied by Sigma-Aldrich.

Data acquisition and analysis
Voltage clamp protocols were generated using PClamp 8
(Molecular Devices). Data were digitized at 2 kHz and
recorded online. Data were stored on computer, and analyzed using Clampfit (Molecular Devices), Excel (Microsoft,
Redmond,
WA)
and
Origin
(Microcal,
Northampton, MA) software. Numerical values in the text
are shown as mean  SEM and were compared statistically using the Student’s two-way t-test in Excel (Microsoft) and Sigmaplot (Systat, San Jose, CA) software. P
values of <0.05 were considered as statistically significant.
The voltage-dependent activation of ICaL was fitted
using the Boltzmann equation:
Activation variable ¼ 1=ð1 þ exp½ðV0:5  Vm Þ=kÞ;

(1)

where Vm = test potential, V0.5 is the membrane potential
exhibiting half-maximal activation, and k is the slope
factor.
The steady-state, voltage-dependent inactivation of ICaL
was described by the equation:
Inactivation variable ¼ 1  ½1=ð1 þ exp½ðV0:5  Vm Þ=kÞ;
(2)
where Vm = the prepulse potential, V0.5 = the membrane
potential at which inactivation was half-maximal and k
describes the slope of the inactivation curve.
The time dependence of current inactivation was
described by the following equation:
y ¼ Af : expðx=sf Þ þ As : expðx=ss Þ;

(3)

where Af and As are the current components described by
the time constants sf and ss.
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The time course of recovery from inactivation of ICaL
was described by the equation:
y ¼ ½A  A expðt=s1 Þþ½B  B expðt=s2 ÞÞ

(4)

where y describes the fraction of recovery of ICaL from
inactivation at time t; A and B describe the data fitted by
each exponential, and s1 and s2 are the time constants for
each exponential.

Results
Cellular capacitance
The AVN isolation produces a heterogeneous population
of cells (Meijler and Janse 1988), so to ensure the identity
of the cells included in the study were nodal in origin, we
only included cells that exhibited regular spontaneous
electrical activity. The cells displayed the characteristic
AVN morphology described in previous studies on rabbit,
guinea pig, and rat AVN myocytes (Hancox et al. 1993;
Yuill and Hancox 2002; Yuill et al. 2010). Cells from the
two groups of animals appeared to be similar in size and
shape, which is consistent with our previous study in rat
AVN that explored the effects of short-term diabetes on
AVN function (Yuill et al. 2010). To assess whether there
were any differences in cell size between the two populations we measured the cell capacitance for all cells studied. Although there was some degree of variation in cell
size within both groups of cells, there was no significant
difference (P > 0.4) between mean capacitance in the

A 60

Capacitance (pF)

50
40
30
20
10
0
CON

Diabetes mellitus reduces peak L-type
calcium current
Using selective recording conditions to fully isolate ICaL,
we examined the effects of long-term DM on ICaL channel
characteristics. Inward currents were elicited by sequential
step depolarizations, from a holding potential of 40 mV,
to more positive test potentials, for a duration of 500 ms.
Application of nifedipine (1 lmol/L), a selective L-type
calcium channel blocker, abolished the inward current at
all test potentials. After prolonged exposure to the diabetic
state, ICaL was clearly and significantly reduced in cells
from STZ-treated rats compared to control.
Figure 2A shows representative families of currents
recorded in control (Fig. 2Aa) and STZ cells (Fig 2Ab).
The currents recorded in the cell from the STZ rat were
substantially smaller than those seen in the age-matched
control. We constructed current–voltage (I–V) relationships by plotting the peak current elicited at each test
potential normalized to cell capacitance (current density),
against membrane potential, and the mean values
(n ≥ 12) are shown in Figure 2B. Peak ICaL occurred at
0 mV and this was reduced by 43% in STZ cells compared to control cells (P < 0.01). Figure 2B shows the
mean I–V relationships in control and STZ cells, where a
significantly smaller ICaL was observed across a range of
test potentials, with significance (*P ≤ 0.05) observed at
all potentials between 10 and +20 mV. Steady state activation curves using equation 1, were plotted to examine
whether there was any significant effect on activation of
the current. The activation curves from the pooled data
are shown in Figure 2C. In control cells, the half-activation potential was 10.9  1.8 mV, with a slope factor,
k, of 11.1  0.9 mV. This was not significantly different
from the STZ cells, where the half-maximal activation
was 9.4  1.4 mV, and the slope factor was
10.3  1.2 mV (P < 0.8, n ≥ 12). Thus, the data show
that in rats with STZ-induced DM, peak ICaL density was
significantly reduced. However, there was no significant
effect on the voltage dependence of activation.
L-type calcium current voltage-dependent
inactivation is modified by diabetes mellitus

STZ

Figure 1. The capacitance of atrioventricular nodal (AVN) myocytes
isolated from control and streptozotocin (STZ) rats. (A) Scatter plot
showing the capacitance measurements for the population of
control and STZ AVN myocytes. There was no significant difference
in cell capacitance and therefore cell size between the two
populations of cells (CON = 29.5  1.6 pF, n = 35,
STZ = 30.9  1.4 pF, n = 29; P > 0.4).
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control group (29.5  1.6 pF; n = 35) and the STZ
(30.9  1.4 pF; n = 29) (see Fig. 1B).

The steady-state inactivation parameters for ICaL were
then determined by delivering a series of prepulses
(1000 ms duration) applied at a frequency of 0.1 Hz,
incrementing (10 mV steps) from 90 mV to +20 mV
from a holding potential of 80 mV. The conditioning
pulses were followed by a test pulse to 0 mV for 500 ms.
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Figure 2. The mean current–voltage relationship for L-type calcium channel current in atrioventricular nodal (AVN) myocytes isolated from control
and streptozotocin (STZ) rats. (Aa) shows families of currents from control AVN myocytes, elicited by incremental 500 ms step depolarizations, at a
frequency of 0.2 Hz, from a holding potential of 50 mV, to more positive test potentials. (Ab) shows representative currents elicited in STZ AVN
myocytes. (B) shows the mean current–voltage (I–V) relation for ICaL in AVN mycoytes from control (open circles) and STZ rats (closed circles,
n ≥ 12). For each cell, the amplitude of ICaL, at different voltages was normalized to cell capacitance, and plotted as a function of voltage. The
mean amplitude of ICaL was significantly smaller in STZ compared to control cells. Asterisks indicate statistical significance (P < 0.05). (C) The mean
steady-state activation curve for ICaL in control and STZ cells. In control cells, the mean value of V0.5 was 10.9  1.8 mV with a slope factor of
11.1  0.9 mV, while in STZ cells, the V0.5 = 9.4  1.4 mV with a slope factor of 10.3  1.2 mV (P < 0.8, n ≥ 12). Therefore, the amplitude of
ICaL was significantly reduced in STZ compared to control, without altering the voltage dependence of ICaL activation.

Families of selected test currents recorded in cells from
control and STZ-treated animals are shown in Figures 3A
and B. Mean data (Fig. 3C; n ≥ 10) were plotted as peak
current measured during the test potential for each prepulse potential, and were fitted to the Boltzmann equation (2). Figure 3C shows a significant (P < 0.01)
hyperpolarizing shift in the half-inactivation potential in
cells from STZ-treated rats (V0.5 = 39.6  2.1 mV,
k = 8.3  0.6 mV), compared to age-matched controls
(V0.5, 32.3  1.4 mV, k = 7.9  0.8 mV).

Diabetes mellitus alters the time
dependence of L-type calcium current
inactivation
Examination of the traces illustrated in Figures 2 and 3
suggest differences in the kinetic properties displayed by
the families of ICaL in control compared to STZ cells.

To explore this further, the time dependence of inactivation of ICaL was compared in the two groups. The kinetics of ICaL have been demonstrated previously to be
described by a biexponential function, where a fast component of the current (Af) can be described by the time
constant (Tf), and a slow current component (As) can
be described by a time constant (Ts) (see equation 3).
Figure 4 shows representative currents elicited by a step
depolarization from 40 mV to 0 mV in a control cell
(Fig. 4A) and a cell from an STZ animal (Fig. 4B). The
current decay was fitted with a biexponential function
(illustrated by the solid line) to determine the inactivation time constants across a range (20 to +30 mV) of
test potentials. Figures 4C and D show the results of this
analysis pooled from eight cells in control animals and
10 from STZ rats. The values for Tf were 5–10-fold
smaller than the values for Ts. Both exhibited voltage
dependence and became increasingly smaller at more
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Figure 3. The voltage dependence of ICaL inactivation in control and streptozotocin (STZ) atrioventricular nodal (AVN) myocytes. (A)
Representative current records obtained from control AVN myocytes during a 300 ms duration voltage command to 0 mV, following
conditioning 1000 ms prepulses to the potentials indicated. Currents were elicited at a frequency of 0.1 Hz. (B) Family of current records from
STZ AVN myocytes, using the same protocol as described above. (C) The voltage dependence of ICaL inactivation. There was a significant
hyperpolarizing shift in the voltage dependence of inactivation in STZ cells, compared to control (CON, V0.5, 32.3  1.4 mV,
k = 7.9  0.8 mV, STZ, V0.5 = 39.6  2.1 mV, k = 8.3  0.6 mV, P < 0.01, n ≥ 10).

positive test potentials in both age-matched control cells
and STZ cells. The amount of current described by each
function did not differ significantly over the range of
test potentials. However, significant differences in the
time constants of inactivation were observed between
cells from control and STZ-treated animals, with the latter exhibiting a significant reduction in the slow decay
constant, Ts, at test potentials between 20 and 0 mV
(P < 0.05). These data demonstrate that in addition to a
reduction in peak amplitude of ICaL, AVN cells from
animals with DM exhibit a much more rapid decay
overall.

Diabetes mellitus slows the restitution
properties of L-type calcium current
The prior experiments established that DM is associated
with changes in the time-dependent and voltage-dependent properties of ICaL inactivation. To complete the analysis, we then studied the effects of DM on recovery from
inactivation. Restitution of ICaL follows a biexponential
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time course and consists of an initial fast phase (T1) succeeded by a slower phase (T2). We measured restitution
using a double-pulse protocol, where currents were elicited by an initial step depolarization (P1) from 40 to
0 mV, and subsequent step depolarizations (Pn) elicited
with increasing intervals from P1 in variable incremental
intervals. Representative current traces for control and an
STZ cell are shown in Figures 5A and B, respectively. The
recovery from inactivation was calculated from the current amplitude for each incrementing interval, as a fraction of the initial peak current (Pn/P1), and was then
plotted against pulse number. The pooled data are shown
in Figure 5C. Analysis shows that there was a significant
delay in the recovery of inactivation in STZ cells compared to control (P < 0.05). When the mean data were
fitted with a biexponential function (Equation 4), the
time constants in control cells (T1 = 10.4  0.9 ms,
T2 = 44.3  1.8 ms) were found to be significantly
(P < 0.05) faster than those for DM-affected cells in STZ
T2 = 149.2  2.4 ms
rats
(T1 = 20.1  1.1 ms,
P < 0.05).
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Figure 4. The time course of ICaL inactivation in control and streptozotocin (STZ) atrioventricular nodal (AVN) myocytes. (A). Representative
current trace (dotted line) elicited by a step depolarization from 40 mV to +0 mV for 500 ms duration in a control cell. The current decay
was fitted with a double exponential function, which overlays the current trace (solid line, blue). (B) Representative current trace elicited using
the same protocol as above, in an STZ AVN myocyte. (C) Mean data for control cells showing the fast (sf) and slow (ss) time constants
describing inactivation, over a range of test potentials (20 to +30 mV). Open circles depict sf, closed circles depict ss. (D) Mean data for sf
and ss describing ICaL inactivation in STZ AVN myocytes, over a range of test potentials (20 to +30 mV). Open circles depict sf, closed circles
depict ss. There was a significant difference between sf and ss in control and STZ myocytes at 20, 10, and 0 mV; P < 0.05, n ≥ 8).

Discussion
To the best of our knowledge, this study is only the second to have investigated the effects of diabetes mellitus
on rat AV node single-cell electrophysiology. The previous study in rat AVN cells was performed 14–21 days
after induction of diabetes while this study was performed
after 12 weeks. These two studies might reflect short-term
and long-term SZT-induced diabetes. We have previously
demonstrated that DM can alter membrane excitability in
rat AVN myocytes, reducing action potential velocity and
upstroke characteristics (Yuill et al. 2010). Here, we
demonstrate that that ICaL is downregulated in the AVN
from rats with STZ-induced type 1 DM, and that this is
likely to underlie the changes in the profile of spontaneous action potentials seen in diabetic AVN cells.

L-type calcium current in rat atrioventricular
node cells
Much of what is currently known about the properties of
AVN cells is derived from rabbit tissue, and this has been
comprehensively reviewed previously (Hancox et al.
2003). Rat AVN has been shown to exhibit the same

structural characteristics as rabbit AVN (Stephenson et al.
2012). While there is limited information regarding AVN
cellular characteristics available from other animal models, such as guinea pig (Yuill and Hancox 2002) and
mouse (Mangoni et al. 2006; Nikmaram et al. 2008; Marger et al. 2011), our previous study in rat (Yuill et al.
2010), reported that the action potential profile and zero
current potential, were comparable to prior findings in
rabbit AVN (Hancox et al. 1993; Munk et al. 1996; Hancox and Mitcheson 1997; Cheng et al. 2009). However, to
date, there has been no detailed characterization, of the
ion channel characteristics of rat AVN.
The generation of normal cardiac rhythm and propagation through the AVN, is dependent on the presence of
voltage-gated L-type calcium channels, which are heteromeric complexes comprising four subunits (a1, b, a2/d),
and the a1 subunit exists in multiple isoforms. Typically,
the two isoforms a1C (Cav1.2) and a1D (Cav 1.3) are
expressed in the heart, with Cav1.3 being expressed predominantly in the SAN and AVN regions (Mangoni et al.
2003; Matthes et al. 2004). Cav1.3 has subtle differences
in its kinetic profile, and is activated at more negative
membrane potentials than Cav1.2, allowing it to contribute to diastolic depolarization (Takimoto et al. 1997).
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Figure 5. The restitution of ICaL in control and streptozotocin (STZ) atrioventricular nodal (AVN) myocytes. Representative ICaL traces elicited
using a double pulse protocol (P1, P2), from a holding potential of 50 mV in control AVN myocytes. The interval between P1 and P2 was
increased incrementally, by 50 ms at a frequency of 0.1 Hz. (A) Representative ICaL traces elicited using the same protocol as above, in STZ
AVN myocytes. (B) Plot showing the recovery from inactivation. For each P1–P2 interval, the magnitude of peak ICaL during P2 was expressed as
a proportion of P1. Recovery of inactivation was significantly slower in STZ AVN myocytes, compared to control cells (P < 0.05, n = ≥8).

Here, we have shown the peak ICaL to be at 0 mV, and
half-maximal activation in control cells to be 10.9 mV,
which is comparable to previous findings in rabbit
(Cheng et al. 2009). However, previous studies in rabbit
AVN have shown activation parameters to be ~10 mV
more depolarized (Hancox et al. 1993; Cheng et al. 2009).
Mouse AVN has been demonstrated to express greater
levels of Cav1.3 than Cav1.2, and ICaL exhibited peak current around 10 mV, with a more hyperpolarized activation profile (Marger et al. 2011).
However, the voltage dependence of ICaL inactivation
parameters that we observed in rat AVN myocytes, were
very similar to previous studies in rabbit (Matthes et al.
2004), V0.5 = 25 mV; V0.5 = 29.4 mV). We also found
that the recovery from inactivation exhibited a biexponential time course, but was significantly faster than previous studies in rabbit (Workman et al. 1999; Cheng
et al. 2009). The time-course of current decay exhibited a
fast and slow component that were voltage dependent,
and these were also similar values to those observed in
rabbit AVN (Hancox and Levi 1994), but were significantly faster than AVN myocytes with abnormal morphology (Nakayama et al. 1984). Previously, nonselective
recording conditions revealed that L-type Ca2+ current
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was reduced and there appeared not to be a shift in the
voltage dependence of activation (Yuill et al. 2010) findings that are consistent with this study where L-type Ca2+
current was recorded under more selective conditions.
There are clearly subtle differences in the ICaL channel
characteristics reported in AVN myocytes of different species. This could reflect the variation in recording parameters within different laboratories and the heterogeneity of
the AVN region used within each study. However, these
changes in profile may well be genuine physiological differences and reflect species differences in expression levels
of Cav1.3 and Cav1.2 isoforms in AVN myocytes (Zhang
et al. 2011). While there are differences between studies,
overall, the properties of ICaL activation, inactivation,
restitution, and the time dependence of inactivation are
largely comparable between rat and rabbit, suggesting that
the rat model of AVN has utility for investigation of cellular electrical function of the region.

Modulation of L-type calcium current by
diabetes mellitus
Changes in action potential profile are generated by alterations in sarcolemmal ionic fluxes, and previous studies
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have indicated that induction of diabetes can modulate a
variety of cardiac ion channels, creating a significant
impact on cardiac function. Available studies of the effects
DM on L-type calcium channel activity in the literature,
are largely focused on rat ventricle, and demonstrate a
diversity of different findings. This variation may derive
from differences in experimental procedures, and implementation and duration of the diabetic state. Some groups
suggest that induction of DM has no significant effect on
ICaL amplitude (Choi et al. 2002; Ding et al. 2006) or voltage-dependent activation, inactivation and time-dependent
current properties (Arikawa et al. 2002). However, these
studies were conducted at room temperature, and this has
been shown to profoundly influence L-type calcium channel properties, particularly with respect to diabetes (Pabbathi et al. 2004), and as such inferences drawn from data
that was obtained under nonphysiological recording conditions may be questionable. Other studies have also
observed no difference in ICaL amplitude after the induction of DM (Lacombe et al. 2007), and while these experiments were performed at 35°C, they were conducted
simultaneously with intracellular calcium measurements,
and thus the chelation of intracellular calcium may have
influenced the electrophysiological findings by altering calcium-dependent inactivation parameters. Conversely,
others have demonstrated an augmentation of ICaL amplitude in diabetic ventricular myocytes compared to control
cells (Jourdon and Feuvray 1993). These experiments were
also performed at room temperature, and the ventricular
myocytes exhibited vastly depolarized resting membrane
potentials (66 mV), indicating the likelihood of cellular
damage resulting from the isolation procedure, and perhaps negating the findings in this study.
There is more general consensus that diabetes inhibits
ICaL amplitude, both in STZ-induced diabetes (Wang
et al. 1995; Chattou et al. 1999; Bracken et al. 2006),
which is in keeping with our current findings in STZ rat
AVN. Previous studies in an insulin-deficient diabetic
mice model (Akita mouse) have shown that the peak
amplitude of L-type calcium current is reduced compared
to control (Lu et al. 2007). Studies of type II diabetes in
mouse (db/db; [Pereira et al. 2006; ] and rat (Zucker diabetic fatty; (Howarth et al. 2011), have also demonstrated
a significant decrease in ICaL amplitude.
While these studies agree that ICaL amplitude is reduced,
the effects of diabetes on ICaL gating characteristics are varied. We saw no change in the activation parameters, which
contrasts with findings of an observed rightward shift in
the activation variable (Lu et al. 2007). Conversely, the
same authors also observed a depolarizing shift in the inactivation of the channel, while in our study, the voltage
dependence of inactivation was shifted in the hyperpolarizing direction, suggesting that at physiological voltages,
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there would be less steady-state current available compared
to control. The leftward shift of inactivation, faster inactivation time course, and slower restitution all point to stabilization of the inactivated channel state in DM. The
combination of reduced L-type Ca2+ current amplitude
and altered inactivation/current restitution might be anticipated both to slow AV nodal conduction and delay AV
nodal action potential restitution. One of the most striking
findings in this study was the difference in the time dependence of current decay between the control and STZ cells.
We observed a significant reduction in the fast and slow
time constants of current inactivation compared to control. While previous studies have observed changes in the
kinetics of ICaL decay following induction of diabetes, the
time course of current decay has been shown to increase
(Chattou et al. 1999; Bracken et al. 2006; Lu et al. 2007). It
is likely that this difference in channel kinetics may relate
to different levels of Cav1.2 and Cav1.3 channel expression
between the AVN region and the ventricle, which may be
further modified by diabetes.
Furthermore, previous studies have identified that
intracellular calcium dynamics are greatly altered in diabetic ventricular myocytes, with a reduction in calcium
transient amplitude, a prolonged time course of the calcium transient, depressed calcium loading of the sarcoplasmic reticulum, leading to an increase in basal
calcium concentrations (Yaras et al. 2005; Pereira et al.
2006). We postulate that in these conditions, an increase
in calcium concentration could facilitate calcium-dependent calcium current inactivation. It is possible therefore
that the decrease in the time constants of current inactivation that we observed in the STZ myocytes, may have
resulted from modulation of the calcium-dependent component of current inactivation. This is of particular
importance, as intracellular calcium homeostasis in nodal
myocytes (SAN and AVN) has been shown to contribute
to spontaneous electrical activity and automaticity, in
concert with sarcolemmal ionic fluxes (Ridley et al.
2008). Any changes in calcium dynamics induced by diabetes could therefore influence action potential generation, fundamentally altering the physiology of the cardiac
conduction system. There is, however, little information
available in the literature concerning measurement of global and local calcium in diabetic SAN and AVN myocytes, which will be of key importance for future
understanding of the effects of diabetes on cardiac function. Our results demonstrate that ICaL activity is downregulated in AVN myocytes from STZ rats, which is in
keeping with previous studies in rat ventricle. While we
have not specifically investigated the mechanisms that
underlie these findings, we speculate that there are
changes in both channel trafficking and modulation of
channel activity by regulatory proteins, based on previous
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work (Lu et al. 2005), which demonstrated that depression of ICaL activity coincided with a reduction in PI3
kinase signaling. Further studies indicated that in type I
diabetic Akita mice, the reduction in ICaL amplitude compared to controls, proceeded from impaired channel trafficking to the cell membrane mediated via the PI3 kinase
signaling pathway (Lu et al. 2007). However, changes in
the channel activation and inactivation kinetics were independent of the PI3 kinase signaling pathway, suggesting
that multiple mechanisms are involved in regulation of
ICaL by diabetes. Given the changes in both channel
amplitude and gating kinetics in our present study, we
speculate that similar processes may be responsible for
altered ICaL in rat AVN myocytes from STZ rats.

Clinical significance and conclusions
Atrioventricular nodal dysfunction can play a vital role in
a variety of cardiac arrhythmias. ICaL is responsible for
the action potential upstroke in AVN myocytes, and is
therefore fundamental to conduction through the region.
Depression of ICaL activity via reduced trafficking to the
membrane, or altered channel kinetics, will decrease AVN
conduction velocity, and can therefore induce ECG
changes, including first to third degree AV block (Watanabe 1981; Watanabe et al. 2012). There is also evidence to
suggest that AV block can initiate the development of QT
prolongation and of Torsade de pointes (Tsuji et al.
2002), which can result in sudden cardiac death. The
reduction in ICaL seen in this study in AVN myocytes following induction of diabetes is consistent with abnormal
AVN function and could contribute to arrhythmogenic
cardiac activity. Arrhythmias are a major cause of mortality in patients with diabetes (Nakou et al. 2012), and it is
therefore imperative that the underlying cellular pathophysiology is investigated in order to elucidate the causes
and potential therapeutic strategies, of cardiac electrical
dysfunction in diabetes.
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